These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10064661)

  • 1. The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children.
    Pearlman DS; Ostrom NK; Bronsky EA; Bonuccelli CM; Hanby LA
    J Pediatr; 1999 Mar; 134(3):273-9. PubMed ID: 10064661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.
    Lazarus SC; Wong HH; Watts MJ; Boushey HA; Lavins BJ; Minkwitz MC
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1725-30. PubMed ID: 9412547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness.
    Dessanges JF; Préfaut C; Taytard A; Matran R; Naya I; Compagnon A; Dinh-Xuan AT
    J Allergy Clin Immunol; 1999 Dec; 104(6):1155-61. PubMed ID: 10588995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
    Smith LJ; Hanby LA; Lavins BJ; Simonson SG
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction.
    Richter K; Jörres RA; Magnussen H
    Eur Respir J; 2000 Apr; 15(4):693-9. PubMed ID: 10780761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast.
    Adelroth E; Inman MD; Summers E; Pace D; Modi M; O'Byrne PM
    J Allergy Clin Immunol; 1997 Feb; 99(2):210-5. PubMed ID: 9042047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.
    Makker HK; Lau LC; Thomson HW; Binks SM; Holgate ST
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1413-8. PubMed ID: 8389103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.
    Edelman JM; Turpin JA; Bronsky EA; Grossman J; Kemp JP; Ghannam AF; DeLucca PT; Gormley GJ; Pearlman DS
    Ann Intern Med; 2000 Jan; 132(2):97-104. PubMed ID: 10644288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure.
    Corren J; Spector S; Fuller L; Minkwitz M; Mezzanotte W
    Ann Allergy Asthma Immunol; 2001 Sep; 87(3):211-7. PubMed ID: 11570617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
    Pearlman DS; van Adelsberg J; Philip G; Tilles SA; Busse W; Hendeles L; Loeys T; Dass SB; Reiss TF
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.
    Kemp JP; Dockhorn RJ; Shapiro GG; Nguyen HH; Reiss TF; Seidenberg BC; Knorr B
    J Pediatr; 1998 Sep; 133(3):424-8. PubMed ID: 9738728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.
    Kemp JP; Minkwitz MC; Bonuccelli CM; Warren MS
    Chest; 1999 Feb; 115(2):336-42. PubMed ID: 10027429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.
    Reiss TF; Hill JB; Harman E; Zhang J; Tanaka WK; Bronsky E; Guerreiro D; Hendeles L
    Thorax; 1997 Dec; 52(12):1030-5. PubMed ID: 9516894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.
    Philip G; Villarán C; Pearlman DS; Loeys T; Dass SB; Reiss TF
    J Asthma; 2007 Apr; 44(3):213-7. PubMed ID: 17454341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction].
    Sun TY; Guo YF; Xu XM; Zhang HS; Hou J; Ke HX; Li YM; Fang BM; Ming SH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):83-7. PubMed ID: 15854387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
    Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction.
    Dahlén B; Roquet A; Inman MD; Karlsson O; Naya I; Anstrén G; O'Byrne PM; Dahlén SE
    J Allergy Clin Immunol; 2002 May; 109(5):789-93. PubMed ID: 11994701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses.
    Melo RE; Solé D; Naspitz CK
    J Allergy Clin Immunol; 2003 Feb; 111(2):301-7. PubMed ID: 12589349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
    Kelloway JS
    Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.